MENU
ZYME
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Zymeworks (ZYME) Ownership - Who owns Zymeworks?

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics... Show more

Profile

Industry
Pharmaceuticals Major
Address
108 Patriot Drive
Phone
+1 302 274-8744
Employees
277
Web
https://www.zymeworks.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.02B
P/E Ratio
N/A
Total Cash
251.93M
Projected Growth
N/A
Total Debt
18.9M
Revenue
134.48M
Risk (Beta)
1.30
Dividend Yield
N/A
Total Cash/Share
3.34
Total Debt/Equity
N/A
Revenue/Share
1.79 USD as % of share price

Fundamentals

ZYME
Capitalization
2.03B
P/E Ratio
N/A
Risk (Beta)
1.30
Dividend Yield
N/A
Total Cash
252M
Total Cash/Share
3.34
Total Debt
18.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.79%
Revenue
134M
ROE
N/A
Book Value
320M
P/B Ratio
6.33
Cash Flow
N/A
Earnings
-0.85
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.1B
Current Ratio
6.94
Current Revenue Per Employee
101150.18
Dividends Per Share - Security
N/A
EBITDA
-57.86M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-14.34
Shares Held By Institutions
1.73B
Shares Outstanding - Current
75.4M
Total Liabilities
77.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
83.470
View a ticker or compare two or three
ZYME
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

a company for cancer & autoimmune treatment

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
108 Patriot Drive
Phone
+1 302 274-8744
Employees
277
Web
https://www.zymeworks.com